To the Editor:
The literature is limited with regard to the treatment of patients after traumatic contact with deer. We present an interesting mechanism of motor vehicle collision vs deer with an isolated penetrating injury of the patient's hand from a deer antler. We also recommend an antibiotic regimen for treating penetrating deer antler injuries.
In the United States, an estimated 150 people die each year in more than 1.5 million traffic accidents involving collisions with deer. This imposes a significant financial burden of $1.1 billion annually on the insurance industry. 1, 2 A collision with a deer may result in massive trauma to the human, with common injury sites involving the head, face, and neck. 3 About one half to two thirds of deer-related car crashes occur in the months of October, November, and December. This increased incidence of collisions is associated with heightened migration due to mating and hunting seasons and with a change in food supplies. 4 Deer commonly feed on green plants around lakes and swamps in the summer, but they head toward dry ground in fall and winter, which may involve crossing rural roads or highways. 3 Since these animals are most active at dawn and dusk, most collisions occur around the times of sunrise and sunset. 1 Deer are usually more cautious and avoid entering an open space in the daylight compared to nighttime, possibly because of the strangeness of a highway environment. Dusk is a period of high activity for deer and a period of low visibility for drivers, which results in an abrupt increase in the crash rate during dusk hours. 1 Depending on the species, a collision with a deer may result in the body of the animal partially penetrating the vehicle through the windshield and/or may result in a violent bending of the roof just above the heads of the front-seat passengers. Typically, the most serious and fatal injuries result from a massive blow to the head, with the risk of injury correlating with the deformation to the car. 3 In late November, an 18-year-old right hand-dominant, previously healthy female presented with an injury to her left ring finger. The patient had been a restrained driver involved in a motor vehicle collision with a deer at 6:00 PM. The patient reported no loss of consciousness and actually witnessed the antler of the deer hitting and penetrating through the windshield; ultimately a portion of the antler landed on the rear seat. The piece of the antler brought in by the patient is shown in Figure 1 .
The tine of the antler lacerated her left ring finger and fractured it at the proximal phalanx in a transverse fashion. This was her sole injury and is depicted in Figure  2 . On presentation to the emergency department, there was some soft tissue swelling with an obvious clinical fracture of the left fourth proximal phalanx. The fracture was unstable. Capillary refill in the fourth digit was excellent, with normal sensation. There was minimal flexor and extensor function on examination. The extensor tendon appeared to be injured longitudinally and was not transected. The plain radiograph of the left hand revealed a displaced transverse fracture of the fourth finger with overlying soft tissue injury. There were no foreign bodies or other bony injuries.
The patient received 1 dose of a gram of cephazolin intravenously and was taken to the operating room for irrigation, exploration, and open-reduction internal fixation of the left fourth digit proximal phalanx by the plastic surgery hand service. Upon achievement of adequate general anesthesia, the wound was explored; it was noted that the extensor mechanism was cut sagittally and the web space had a complex laceration. The wound was irrigated with a Pulsavac (Zimmer Inc, Swindon, UK), and with fluoroscopic guidance, 2 cross-oblique 0.035 K wires were placed across the fracture site. The extensor mechanism was repaired with 5-0 Ethibond sutures, and the skin was closed using 4-0 interrupted nylon sutures. The total length of the closure was 8 cm. The hand was placed in a splint for protection. The patient was later discharged home with no further antibiotics. At follow-up the patient was started on active range of motion of the left hand with occupational therapy. Six weeks later, the pins were removed. The patient recovered well, with full function of her left hand and complete recovery of her fourth finger.
The trajectory force from the tine of the deer antler affected the patient's left ring finger and resulted in an open proximal phalanx fracture. Any accident caused by contact with a deer carries a heightened possibility for transmission of infectious disease. The most common infectious diseases associated with deer collisions include Arcanobacterium pyogenes, Haemonchus controtus, Salmonella, Mycobacterium avium, and Paratuberculosis. 5 About 13% of road-killed deer exhibit debilitating conditions predisposing them to motor vehicle collisions. 5 The typical problems revealed during necropsy include chronic purulent infections involving the cranial region, usually intracranial abscesses and/or purulent meningoencephalitis. At necropsy many deer have evidence of missing antlers, open wounds, or scars around the antlers or atypical antlers secondary to structural fragility. Other bacteria cultured from wounds in close proximity to the deer antlers have included Bacteroides, Citrobacter, Corynebacterium, Enterobacter, Pasteurella multocida, Serratia marcesens, Staphylococcus aureus, and Staphylococcus sciuri. 5 Given this vast range of bacteria, a broad antibiotic coverage, to include gram negatives and anaerobes, would be an appropriate regimen in patients injured by deer. The literature is limited with regard to the surgical treatment of patients after traumatic contact with deer, and the optimal duration of antibiotic therapy for grossly contaminated wounds is still controversial. Generally a 3-day course is recommended, though 24 hours of antibiotics may be sufficient. 6 However, if the injury or wound site becomes infected, a 14-day course of treatment should be considered for soft tissue wounds and a 21-day course for infections involving joints or bones. 7 For prophylaxis, all such patients should receive tetanus prophylaxis as indicated, aggressive irrigation of wounds, and an antibiotic regimen with good gram-negative and anaerobic coverage. The antibiotics should include a third-or fourth-generation cephalosporin, such as ceftriaxone or cefepime, respectively, for broad gram-positive and gram-negative coverage and a tetracycline, such as doxycycline or minocycline, for anaerobic and atypical coverage. An alternative for penicillin-or cephalosporinallergic patients would be a fluoroquinolone such as ciprofloxacin or levofloxacin.
In summary, for a patient presenting to the emergency department within 3 hours of an open fracture from a penetrating deer antler injury, we recommend a one-time prophylactic dose of intravenous ceftriaxone (2 g) and oral doxycycline (100-200 mg).
Wild Flowers and Mad Honey
To the Editor:
One unusual form of food poisoning, commonly seen in the eastern Black Sea region, is caused by toxic honey, which is familiar to local people and which is known as ''mad honey.'' It has been known to be poisonous since 401 BC. 1 Grayanotoxins, which are extracted by bees from the flowers of rhododendron species, are the main compounds responsible for this poisoning. Ericaceae is one of the largest dicotelydon genera. The name ''rhododendron'' derives from the Greek rhodos, meaning ''rose,'' and dendron, meaning ''tree.'' There are some 700 different species in the area comprising China, Tibet, Myanmar, Assam, and Nepal; nearly 300 species in New Guinea; many in Japan; others in tropical Asia from Indochina to Indonesia and the Philippines; and a small number occur in Europe and North America. Purpleflowered (Rhododendron ponticum) ( Figure 1 ) and yellow-flowered (Rhododendron luteum) (Figure 2 ) rhododendrons have become pernicious woody weeds in northern Turkey. 2 The former are also known as ''black poison'' and the latter as ''yellow poison.'' As a result of the grayanotoxins they contain, the flowers of these 2 rhododendron species, which are widely found in the mountains that extend along the Black Sea coast of northern Turkey, may lead to poisoning of honey made by local producers and produced by wild bees. The grayanotoxins bind to the sodium channels in cell membranes. These compounds prevent inactivation; thus, excitable cells (nerve and muscle) are maintained in a state of depolarization, during which entry of calcium into the cells may be facilitated. 3 Toxic Rhododendron species, particularly R ponticum, are commonly used in folk medicines of the Black Sea region. R ponticum is widely used both internally and externally as an analgesic for treatment of rheumatic or dental pain, common viral upper respiratory infections, and edema. 4 ''Mad honey'' is used as an alternative medicine for the treatment of gastric pains, bowel disorders, and hypertension and is also believed to be a sexual stimulant.
Beekeeping is a common activity among the inhabitants of the eastern Black Sea region. Native Caucasian bees (Apis mellifera caucasica), which fly in an area of only some 5 km, 2 are used in the traditional method of honey production. Since rhododendrons are long-lived plants, beekeepers know which honey is ''mad.'' Honey produced in springtime is more toxic and sometimes contains higher concentrations of grayanotoxins than that produced in other seasons. 5 Well-known toxic effects of honey poisoning are bradycardia, cardiac arrhythmia, hypotension, nausea, vomiting, sweating, salivation, dizziness, weakness, loss of consciousness, fainting, blurred vision, chills, cyanosis, and convulsions. 5, 6 Poisoning is frequently seen in this region, 7 and patients generally recover spontaneously without reporting to health institutions. The majority of those who do seek medical care recover with 0.5 to 1.0 mg of atropine and controlled fluid replacement. In rare, life-threatening cases, cardiac arrhythmias requiring cardiac pacing may occur. The potential hazards of these 2 wild flowers need to be appreciated along with their aesthetic qualities. 
High-Altitude Pulmonary Edema Getting Worse After Descent? An Unlikely Event

To the Editor:
We read with great interest the article by Strote and Prutkin 1 because it potentially represents the first reported case of high-altitude pulmonary edema getting worse following descent to sea level. Their claim is based on an assertion that they effectively ruled out pulmonary embolism or other underlying cardiac disease. After reading their case description, however, we take issue with their arguments. The authors presented the results of an echocardiogram performed at the time of the patient's emergency room presentation. Unfortunately, pulmonary artery pressure measurements were not provided, and the authors do not make it clear as to whether they were simply not measured or could not be measured due to the absence of a tricuspid regurgitant jet. This is an important oversight, because pre-existing pulmonary hypertension could provide a reason why dyspnea might worsen, even with descent to lower elevation; the alveolar hypoxemia induced by the pulmonary edema might cause hypoxic pulmonary vasoconstriction and a further rise in pulmonary artery pressure. We presented a case in which an individual with no history of baseline pulmonary hypertension developed pulmonary edema at 7800 feet in elevation and upon descent to 4900 feet in elevation had a systolic pulmonary artery pressure of 45 to 50 mm Hg. 2 More important, we do not think the authors definitively ruled out the possibility of pulmonary embolism as a cause of his worsening dyspnea. Their work-up consisted of a negative D-dimer assay and no further imaging. Published research has shown that among patients with a low clinical probability of pulmonary edema, a normal D-dimer level is associated with a 99% likelihood of not having pulmonary embolism. 3 We argue that this patient did not have a low clinical probability of pulmonary embolism. Upon presenting to the emergency room, he had a hematocrit of 51%, which suggests he may have been volume depleted. In addition, the drive from Mount Rainier to Seattle takes 2.5 to 3 hr, and the patient went to sleep upon arriving home, suggesting that he had a period of immobility during his dehydrated state that might have increased his risk of deep venous thrombosis and pulmonary embolism. Finally, it is not known if this patient has a previously unrecognized predisposition to thromboembolism. This could be significant, because a recent study 4 indicates that moderate degrees of hypoxia (equivalent to 1800-2100 m in altitude) lead to increased levels of thrombin-antithrombin complex, prothrombin 1ϩ2, and D-dimer in people with underlying risk factors for coagulopathy, such as the Factor V Leiden mutation. Taking into account these clinical factors, this patient warranted additional imaging studies to effectively rule out pulmonary embolism. It is also important to keep in mind that whereas the sensitivity of the D-dimer assays is high for segmental or larger emboli, it falls to roughly 50% for subsegmental emboli. 4 In the setting of resolving edema, subsegmental emboli would be enough to increase this patient's dyspnea.
Finally, the fact that he was asymptomatic at a followup appointment 2 months after his acute episode does not rule out the possibility of a pulmonary embolus. With resolution of the pulmonary edema, it is possible a young, fit person would be asymptomatic with a subsegmental pulmonary embolism. In addition, the body's natural lytic mechanisms would be expected to resolve the thrombus, and, in the absence of an underlying coagulopathy or other predisposing factor for clot formation, he would not be expected to have further episodes of pulmonary embolism.
In the absence of complete data regarding pulmonary artery pressures and further diagnostic imaging, we do not feel the authors can make the claim that this is a case of high-altitude pulmonary edema that worsened with descent to lower elevation.
Reply to High-Altitude Pulmonary Edema Getting Worse After Descent? An Unlikely Event
To the Editor:
We appreciate the comments of Luks and Swenson but disagree with their alternative explanations.
With regard to their question of underlying pulmonary hypertension as the cause of respiratory distress, our patient had only trace tricuspid regurgitant jet, and, therefore, no estimation of the pulmonary artery systolic pressure could be made. Although it is true that underlying pulmonary hypertension may lead to a propensity for hypoxia and dyspnea, the patient had no known risk factors for pulmonary hypertension nor other echo findings that would have suggested a cardiac etiology (eg, atrial septal defect) or indirect evidence (eg, right ventricular dilation or dysfunction) of pulmonary hypertension in an otherwise healthy young male.
In terms of the risk for pulmonary embolus, we disagree that the patient had more than a low clinical probability of having a pulmonary embolus. He had a score of 1.5 using the widely accepted Wells clinical decision rule 1 (heart rate Ͼ100 bpm), which suggests a low risk of having a pulmonary embolism. In this setting of a low clinical probability along with a negative D-dimer, there is up to a 99.6% negative predictive value in ruling out a pulmonary embolism in patients presenting to the emergency department, 2 thus making further imaging unnecessary.
Furthermore, it is unclear if the results of the article involving coagulation factors after air travel 3 are applicable to high-altitude mountaineering. That study describes subjects who are immobile for 8 hours while in flight. Although both mountaineering and air travel involve hypobaric hypoxia, mountaineering involves vigorous activity, which has an unknown effect on the levels of coagulation factors.
Finally, the patient's clinical presentation and course is truly inconsistent with a diagnosis of pulmonary embolus. A pulmonary embolus significant enough to present with severe hypoxia and diffuse pulmonary infiltrates would not likely be subsegmental or resolve completely over 24 hours.
We believe our patient's clinical diagnosis was most consistent with a late presentation of high-altitude pulmonary edema. We were delighted to read one of the few research articles on Nepali porters in the Mount Everest region. 1 Being from this region, we were particularly interested in reviewing the article meticulously, learning from its findings, and applying the information to our medical practice. While studying the article, we came across some points that we hope the authors will clarify. The first question relates to the methods and the exclusion criteria for enrollment into the study, which were acute mountain sickness (AMS), diabetes mellitus, glaucoma, epilepsy, or sulphonamide allergy. How were these conditions considered? From history, any medical documentation, drugs the porters had taken, or investigations done at the research site? It appears to us that most Nepalese do not know about these conditions. The second point is the incidence of AMS found:
11.9%; this is very low in comparison with previous studies. 2 Also, AMS was more common in the people taking acetazolamide than in the placebo group. How can this study, therefore, support that acetazolamide prevents AMS?
The third point for consideration is the dropout rate, which the authors opine was related to the porters' possible cultural aversion to taking the drugs. Did the authors find any taboo that discouraged the porters from taking the drugs?
Fourth, the study concludes that there was poor compliance with acetazolamide and that its recommendation to Nepali porters was, therefore, impractical. At the same time, however, the authors suggest that nonpharmacological measures, such as adequate rest days and slow ascent rates, would be good recommendations. In our experience, and as the authors mentioned, these porters are there for employment and must wait for the tourists, thus limiting their options regarding rest days and ascent rate. We therefore believe this recommendation is even less practical.
The final point is that better education has resulted in prompt action being taken after the development of symptoms of AMS and high-altitude cerebral edema in trekkers, 3 and research shows that large populations of at-risk, high-altitude travelers are relatively naive to the dangers of altitude sickness. 4 Thus, we believe that better counseling about the dangers of AMS and the importance of taking prophylactic drugs is crucial even in Nepali porters. Were the education and counseling in this study adequate such that the porters fully understood the hazards of AMS and the usefulness of drugs?
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